Compare III & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | III | PMI |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | United States | United States |
| Employees | 1300 | N/A |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.9M | 202.7M |
| IPO Year | 2006 | N/A |
| Metric | III | PMI |
|---|---|---|
| Price | $4.56 | $1.12 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 313.6K | ★ 1.6M |
| Earning Date | 06-09-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.78% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $192,745,000.00 | N/A |
| Revenue This Year | $4.62 | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $36.77 | ★ N/A |
| Revenue Growth | ★ 4.51 | N/A |
| 52 Week Low | $3.17 | $0.96 |
| 52 Week High | $6.45 | $13.68 |
| Indicator | III | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 36.04 |
| Support Level | $4.48 | N/A |
| Resistance Level | $5.05 | $2.52 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 25.00 | 21.74 |
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.